Clinical Study

Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure

Table 3

Demographic statistics of the three subgroups (24h, 48h, and 72h infusion).

InfusionStart48 h72 h

BNP-Concentration (pg/mL)24 h-Group 1 1 1 4 ± 3 2 0 4 9 4 ± 1 0 1 ( 𝑃 > . 1 ) 5 4 5 ± 9 5 ( 𝑃 > . 1 )
48 h-Group 1 2 1 5 ± 1 9 3 7 4 8 ± 1 5 1 ( 𝑃 < . 0 0 0 1 ) 5 6 8 ± 1 0 4 ( 𝑃 < . 0 0 0 1 )
72 h-Group 9 1 2 ± 1 5 9 6 0 1 ± 1 8 ( 𝑃 < . 0 4 ) 5 3 5 ± 2 9 ( 𝑃 = . 0 0 4 )

QRS Duration (msecs)24 h-Group 1 5 1 ± 6 1 5 9 ± 1 2 ( 𝑃 > . 1 ) 1 6 9 ± 5 ( 𝑃 > . 1 )
48 h-Group 1 4 5 ± 6 1 5 9 ± 8 ( 𝑃 > . 1 ) 1 4 0 ± 6 ( 𝑃 = . 0 6 )
72 h-Group 1 5 3 ± 8 1 4 5 ± 1 0 ( 𝑃 > . 1 ) 1 4 7 ± 6 ( 𝑃 = . 0 5 )

Data are presented as Mean ± Standard Deviation.